Advanced age and unhealthy dietary habits contribute to the increasing incidence of
obesity and
type 2 diabetes. These metabolic disorders, which are often accompanied by oxidative stress and compromised
nitric oxide (NO) signaling, increase the risk of adverse cardiovascular complications and development of
fatty liver disease. Here, we investigated the
therapeutic effects of dietary
nitrate, which is found in high levels in green leafy vegetables, on
liver steatosis associated with
metabolic syndrome. Dietary
nitrate fuels a
nitrate-
nitrite-NO signaling pathway, which prevented many features of
metabolic syndrome and
liver steatosis that developed in mice fed a high-fat diet, with or without combination with an inhibitor of NOS (
l-NAME). These favorable effects of
nitrate were absent in germ-free mice, demonstrating the central importance of host microbiota in bioactivation of
nitrate. In a human liver cell line (HepG2) and in a validated hepatic 3D model with primary human hepatocyte spheroids,
nitrite treatment reduced the degree of metabolically induced steatosis (i.e., high
glucose,
insulin, and
free fatty acids), as well as drug-induced steatosis (i.e.,
amiodarone). Mechanistically, the salutary metabolic effects of
nitrate and
nitrite can be ascribed to
nitrite-derived formation of NO species and activation of
soluble guanylyl cyclase, where
xanthine oxidoreductase is proposed to mediate the reduction of
nitrite. Boosting this
nitrate-
nitrite-NO pathway results in attenuation of
NADPH oxidase-derived oxidative stress and stimulation of
AMP-activated protein kinase and downstream signaling pathways regulating lipogenesis,
fatty acid oxidation, and
glucose homeostasis. These findings may have implications for novel nutrition-based preventive and therapeutic strategies against
liver steatosis associated with metabolic dysfunction.